2013.05.16… read more
Latisse is the first and only FDA-approved medication created to treat people with hypotrichosis, a condition where people have very few eyelashes. Manufactured by Allergan (the same company that manufactures Botox and Juvéderm), Latisse provides users with longer, fuller, thicker, and darker eyelashes in as little as 16 weeks. It contains an active ingredient called Bimatoprost, which is known for its ability to enhance eyelash growth. Ask us how to sign up for Brilliant Distinctions Program to save on your next purchase of Latisse.